Read about how Austin’s Savara Pharmaceuticals Banks $11.4M for Phase II study of AeroVanc Drug.
http://bionews-tx.com/news/2013/03/20/austins-savara-pharmaceuticals-banks-11-4m-for-phase-ii-study-of-aerovanc-drug/
Read about how Austin’s Savara Pharmaceuticals Banks $11.4M for Phase II study of AeroVanc Drug.
http://bionews-tx.com/news/2013/03/20/austins-savara-pharmaceuticals-banks-11-4m-for-phase-ii-study-of-aerovanc-drug/
No comments:
Post a Comment